1.93
0.52%
0.01
After Hours:
1.94
0.01
+0.52%
Standard Biotools Inc stock is traded at $1.93, with a volume of 923.81K.
It is up +0.52% in the last 24 hours and down -9.39% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
See More
Previous Close:
$1.92
Open:
$1.91
24h Volume:
923.81K
Relative Volume:
0.31
Market Cap:
$707.05M
Revenue:
$106.34M
Net Income/Loss:
$-74.66M
P/E Ratio:
-1.8208
EPS:
-1.06
Net Cash Flow:
$-46.12M
1W Performance:
+3.21%
1M Performance:
-9.39%
6M Performance:
-28.78%
1Y Performance:
-33.45%
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
2 TOWER PLACE, SOUTH SAN FRANCISCO
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Standard BioTools Inc (LAB) receives a Buy rating from TD Cowen - Knox Daily
Standard BioTools Inc (LAB) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Standard BioTools (NASDAQ:LAB) Stock Quotes, Forecast and News Summary - Benzinga
Standard BioTools Inc [LAB] Shares Fall -7.11 % on Wednesday - Knox Daily
Standard BioTools Inc (LAB) Stock: Navigating Drops and Gains - The InvestChronicle
A significant driver of top-line growth: Standard BioTools Inc (LAB) - SETE News
Rhumbline Advisers Boosts Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Victory Capital Management Inc. Purchases 10,067 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Magnetar Financial LLC Reduces Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Can you now get a good deal on Standard BioTools Inc’s shares? - US Post News
Smartsheet to Be Bought in $8.4 Billion Deal. The Stock Is Rising. - Barron's
Metric Analysis: Standard BioTools Inc (LAB)’s Key Ratios in the Limelight - The Dwinnex
Standard BioTools Achieves New Record of the Most Protein - GlobeNewswire
Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform - StockTitan
Magnetar Financial LLC Sells 822,392 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
StandardAero, Inc. (SARO) Plans to Raise $1,000 Million in October 2nd IPO - Defense World
Investing in Standard BioTools Inc (LAB): What You Must Know - Knox Daily
StandardAero sets terms for planned IPO at valuation of up to $7.5 billion - MarketWatch
Latham-Led Aerospace Giant StandardAero Preps $1B IPO - Law360
Standard BioTools (NASDAQ:LAB) Trading Down 4.5% - Defense World
Standard BioTools (NASDAQ:LAB) Trading Down 4.5% - MarketBeat
Carlyle-backed StandardAero targets $7.5 billion valuation in US IPO - WTVB
StandardAero $1B IPO Amid Late-Year Surge in Public Offerings - USA Herald
Carlyle-backed StandardAero targets $7.5 bln valuation in US IPO - Reuters
SARO IPO NewsCarlyle-backed aircraft maintenance provider StandardAero sets terms for $1.0 billion IPO - Renaissance Capital
Carlyle-Backed StandardAero IPO Seeks to Raise $1.1 Billion - Financial Post
StandardAero launches IPO, seeks $7.5B valuation - baha news
StandardAero Outlines IPO Terms With $7.5 Bln Valuation - MarketWatch
Pacer Advisors Inc. Has $29.74 Million Holdings in Standard Motor Products, Inc. (NYSE:SMP) - Defense World
Discovery Capital Management LLC CT Has $4.63 Million Stake in StoneCo Ltd. (NASDAQ:STNE) - Defense World
Carlyle-backed StandardAero targets $7.5 billion valuation in US IPO - Marketscreener.com
StandardAero Announces Launch of Initial Public Offering - Business Wire
Form S-1/A StandardAero, Inc. - StreetInsider.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 2.4% - Defense World
Shareholders in Standard BioTools (NASDAQ:LAB) are in the red if they invested three years ago - Yahoo Finance
STAAR Surgical (NASDAQ:STAA) Given Hold Rating at Needham & Company LLC - Defense World
Bank of New York Mellon Corp Boosts Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools (NASDAQ:LAB) Shares Gap Down to $2.00 - MarketBeat
LAB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Standard BioTools proteomics profiling reveals unique - GlobeNewswire
Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH) - StockTitan
Standard BioTools Inc [LAB] Stock bought by Insider Taich Adam for $91725.0 - Knox Daily
Standard BioTools (NASDAQ:LAB) Stock Price Down 2.4% - MarketBeat
Was anything positive for Standard BioTools Inc (LAB) stock last session? - US Post News
Market Recap: Standard BioTools Inc (LAB)’s Positive Momentum, Closing at 2.09 - The Dwinnex
TD Cowen maintains Buy rating on Standard BioTools stock - Investing.com
Standard BioTools Inc (LAB) expanding its growth trajectory ahead - SETE News
Market Participants Recognise Standard BioTools Inc.'s (NASDAQ:LAB) Revenues Pushing Shares 33% Higher - Simply Wall St
Taking a look at what insiders are doing to gauge the Standard BioTools Inc (LAB)’s direction - Knox Daily
You might want to take a look at Standard BioTools Inc (LAB) now - SETE News
Standard BioTools Inc (LAB) gets rating Initiated from TD Cowen - Knox Daily
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):